Chronic pain affects about twenty% in the population around the globe, and lots of patients encounter its detrimental effects on their own quality of daily life and mental health. Ketamine, an NMDA antagonist that also functions on opioid receptors, has been examined for a pharmacologic choice for chronic pain situations. RCTs have shown that ketam